372 related articles for article (PubMed ID: 16229087)
1. Gliomas: advances in molecular analysis and characterization.
Boudreau CR; Yang I; Liau LM
Surg Neurol; 2005 Oct; 64(4):286-94; discussion 294. PubMed ID: 16229087
[TBL] [Abstract][Full Text] [Related]
2. [Classification of gliomas. Current progress and perspectives].
Capper D; Reifenberger G
Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
[TBL] [Abstract][Full Text] [Related]
3. Molecular Classification of Diffuse Gliomas.
Kalidindi N; Or R; Babak S; Mason W
Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
[TBL] [Abstract][Full Text] [Related]
4. Progress on molecular biomarkers and classification of malignant gliomas.
Zhang C; Bao Z; Zhang W; Jiang T
Front Med; 2013 Jun; 7(2):150-6. PubMed ID: 23681890
[TBL] [Abstract][Full Text] [Related]
5. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
6. Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling.
Caskey LS; Fuller GN; Bruner JM; Yung WK; Sawaya RE; Holland EC; Zhang W
Histol Histopathol; 2000 Jul; 15(3):971-81. PubMed ID: 10963139
[TBL] [Abstract][Full Text] [Related]
7. DNA-microarray analysis of brain cancer: molecular classification for therapy.
Mischel PS; Cloughesy TF; Nelson SF
Nat Rev Neurosci; 2004 Oct; 5(10):782-92. PubMed ID: 15378038
[TBL] [Abstract][Full Text] [Related]
8. Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.
Fuller GN; Mircean C; Tabus I; Taylor E; Sawaya R; Bruner JM; Shmulevich I; Zhang W
Oncol Rep; 2005 Sep; 14(3):651-6. PubMed ID: 16077969
[TBL] [Abstract][Full Text] [Related]
9. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
10. Progress in the application of molecular biomarkers in gliomas.
Wang J; Su HK; Zhao HF; Chen ZP; To SS
Biochem Biophys Res Commun; 2015 Sep; 465(1):1-4. PubMed ID: 26253473
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.
Persson O; Krogh M; Saal LH; Englund E; Liu J; Parsons R; Mandahl N; Borg A; Widegren B; Salford LG
J Neurooncol; 2007 Oct; 85(1):11-24. PubMed ID: 17634744
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets.
Fuller GN; Hess KR; Rhee CH; Yung WK; Sawaya RA; Bruner JM; Zhang W
Brain Pathol; 2002 Jan; 12(1):108-16. PubMed ID: 11771519
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
Paul Y; Mondal B; Patil V; Somasundaram K
Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
[TBL] [Abstract][Full Text] [Related]
14. Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population.
Trabelsi S; Chabchoub I; Ksira I; Karmeni N; Mama N; Kanoun S; Burford A; Jury A; Mackay A; Popov S; Bouaouina N; Ben Ahmed S; Mokni M; Tlili K; Krifa H; Yacoubi MT; Jones C; Saad A; H'mida Ben Brahim D
Mol Neurobiol; 2017 May; 54(4):2381-2394. PubMed ID: 26957305
[TBL] [Abstract][Full Text] [Related]
15. Molecular characteristics of diffuse lower grade gliomas: what neurosurgeons need to know.
Young JS; Gogos AJ; Morshed RA; Hervey-Jumper SL; Berger MS
Acta Neurochir (Wien); 2020 Aug; 162(8):1929-1939. PubMed ID: 32472378
[TBL] [Abstract][Full Text] [Related]
16. Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.
Chen R; Ravindra VM; Cohen AL; Jensen RL; Salzman KL; Prescot AP; Colman H
Neurosurg Focus; 2015 Mar; 38(3):E2. PubMed ID: 25727224
[TBL] [Abstract][Full Text] [Related]
17. Comparative expression analysis reveals lineage relationships between human and murine gliomas and a dominance of glial signatures during tumor propagation in vitro.
Henriquez NV; Forshew T; Tatevossian R; Ellis M; Richard-Loendt A; Rogers H; Jacques TS; Reitboeck PG; Pearce K; Sheer D; Grundy RG; Brandner S
Cancer Res; 2013 Sep; 73(18):5834-44. PubMed ID: 23887970
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value and their clinical implication of 89-gene signature in glioma.
Shahid M; Cho KM; Nguyen MN; Choi TG; Jo YH; Aryal SN; Yoo JY; Yun HR; Lee JW; Eun YG; Lee JS; Kang I; Ha J; Yoon HJ; Kim SY; Kim SS
Oncotarget; 2016 Aug; 7(32):51237-51250. PubMed ID: 27323413
[TBL] [Abstract][Full Text] [Related]
19. Primary brain tumours in adults.
Lapointe S; Perry A; Butowski NA
Lancet; 2018 Aug; 392(10145):432-446. PubMed ID: 30060998
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis to complement histopathological diagnosis of brain tumors.
Nakamura M; Shimada K; Ishida E; Nakase H; Konishi N
Histol Histopathol; 2007 Mar; 22(3):327-35. PubMed ID: 17163407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
